Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
A key profitability switch at Intel has occurred, according to a recent market analysis, even as the company’s manufacturing business continues to lose money. The split underscores why investor focus remains split between near-term margin improvement and longer-horizon spending on capacity and process technology.
THE APEX TIMES
THE APEX TIMES
A new market commentary argues Microsoft’s latest results show cost discipline and customer pull-through, and that the post-earnings optimism is likely to persist.
THE APEX TIMES
A new market commentary says Microsoft’s strength is its ability to charge for AI use while expanding profitability, even as the company ramps up cloud and artificial intelligence capacity.
THE APEX TIMES
After a fresh earnings result, Meta Platforms is again at the center of a familiar debate: how much artificial intelligence spending is enough to drive durable growth, and how quickly that spending should translate into profits.
THE APEX TIMES
A market-focused report pointed to Meta’s recent 18% decline and argued that heavy spending could still translate into a higher stock level by 2027, with more than 50 analysts apparently aligned on the timing.
THE APEX TIMES
A market watch post circulated among Zacks.com users on July 31 highlighted Pfizer (PFE) as a “trending” stock, pointing readers to what the shares could be indicating going forward. The post itself, however, does not provide detailed new fundamentals in the material available here.
THE APEX TIMES
The healthcare giant said it is reorganizing parts of its supply network, with the changes largely linked to its Innovative Medicine segment and involving exits from certain facilities.
THE APEX TIMES
A recent Yahoo Finance post says more investors have been looking at Eli Lilly, pointing readers to the kinds of company-specific factors that can move the stock. The post itself is framed as a prompt rather than a detailed update.
THE APEX TIMES
A market-focused post points to increased attention from Zacks users on Leidos Holdings, a defense contractor whose shares trade on the NYSE under the ticker LDOS.
